Table 1.
Echocardiographic analysis of the mice.
| VEH | C16:1n7 | ISO | C16:1n7/ISO | |
|---|---|---|---|---|
| IVSd (mm) | 0.6613 ± 0.048 | 0.6488 ± 0.068 | 0.6817 ± 0.095 | 0.6191 ± 0.083 |
| PWd (mm) | 0.5818 ± 0.073 | 0.5626 ± 0.063 | 0.5639 ± 0.061 | 0.5567 ± 0.055 |
| LVIDd (mm) | 3.717 ± 0.202 | 3.602 ± 0.207 | 3.882 ± 0.174 | 3.890 ± 0.209 * |
| FS (%) | 26.12 ± 5.92 | 26.67 ± 5.89 | 24.85 ± 3.87 | 26.26 ± 2.33 |
| LVM (mg) | 74.65 ± 10.9 | 72.60 ± 5.46 | 80.92 ± 13.11 | 81.88 ± 7.51 |
| HW (mg) | 113.8 ± 5.95 | 113.7 ± 10.1 | 122.6 ± 8.63 | 121.3 ± 5.72 |
Final echocardiographic analysis, performed after 22 days of treatment. Values are shown as mean ± standard error of the mean; IVSd, septum thickness during diastole; PWd, posterior wall thickness during diastole; LVIDd, LV internal diameter during diastole; FS, fraction shortening; LVM, left ventricular mass; HW, heart weight. n = 8–10 per group; * = p < 0.05 C16:1n7 vs. C16:1n7/ISO; 2-way ANOVA (Tukey post-test).